title: [Active surveillance is a useful strategy in the management of patients with low-risk prostate cancer].
abstract: Radical prostatectomy has in randomised settings failed to demonstrate a survival difference in patients with low-risk prostate cancer when tested against an observational strategy. Active surveillance has been introduced in order to reduce overtreatment by distinguishing between cancers with a biological potential, and truly indolent cancers best left untreated. Preliminary results from large prospective active surveillance cohorts are promising; however, uncertainties persist concerning optimal patient selection and follow-up, as well as the long-term safety.
authors.forename: Frederik Birkebaek
authors.initials: FB
authors.lastname: Thomsen
authors.forename: Klaus
authors.initials: K
authors.lastname: Brasso
mesh_terms: D018450:Disease Progression; D006801:Humans; D008297:Male; D060787:Neoplasm Grading; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000628:therapy; D018570:Risk Assessment; D019564:Unnecessary Procedures; D057832:Watchful Waiting
chemical_list: D017430:Prostate-Specific Antigen